Veeva Systems Inc. (VEEV) Sinks 11.96% After Earnings, Beats EPS, Beats Revenue

2025-11-21 · Stocks · QuoteReporter

Post Earning Analysis

Veeva Systems Inc. (VEEV) Sinks 11.96% After Earnings, Beats EPS, Beats Revenue

Veeva Systems, Inc. is a leading provider of cloud-based solutions tailored for the global life sciences industry. Founded in 2007 and headquartered in Pleasanton, California, Veeva offers specialized software that supports pharmaceutical and life sciences companies in maintaining regulatory compliance and enhancing efficiency across critical business functions. The company’s offerings include customer relationship management, regulated content management, and data management solutions.

Veeva Systems Inc. (VEEV) recently reported its Q3 2026 earnings, surpassing expectations in both earnings and revenue, which has stirred significant attention in the stock market. Despite the strong performance, Veeva’s stock is on track for its largest drop since 2023. The company not only beat quarterly expectations but also raised its full-year outlook, suggesting confidence in continued growth. This juxtaposition of strong earnings against a sharp stock price drop may be attributed to broader market movements or potentially to investors’ reactions to other underlying aspects of the earnings report that were not immediately apparent.

The broader stock market showed mixed signals, with the Dow rallying on rate-cut hopes, while tech stocks like Nvidia, Palantir, and AMD faced selling pressures. These market conditions could also contribute to the volatility in Veeva’s stock despite its positive earnings report. The situation underscores the complexity of market reactions to earnings announcements, where investor expectations and broader market trends can heavily influence stock movements.

The current price of the asset is $246.72, showing a significant drop of 11.96% today, placing it closer to its recent weekly low of $237.28. This price is substantially lower than both the 52-week and YTD highs of $310.5, indicating a downward trend with a 20.54% decrease from these peaks. The asset is currently performing better than its 52-week and YTD lows, which suggests some resilience above the $201.54 level.

The moving averages reveal a bearish sentiment with the current price falling below the 20-day, 50-day, and 200-day moving averages by approximately 13.96%, 14.26%, and 6.46% respectively. This positioning below key moving averages typically indicates a lack of bullish momentum in the short to medium term.

Technical indicators reinforce this bearish outlook. The RSI at 21.77 is deep into the oversold territory, which might suggest a potential for rebound or at least stabilization in the near term, though it also highlights the strong recent selling pressure. The MACD value of -6.16 further supports the view of ongoing bearish momentum, indicating that the price might continue to struggle before any significant recovery occurs.

Veeva Systems Inc. reported robust financial results for the third quarter of 2026, showcasing significant growth across key metrics. The company’s total revenue surged by 16% to $811.2 million, up from $699.2 million in the same quarter the previous year. Subscription services, a critical component of Veeva’s revenue, grew by 17% to $682.5 million. The company also saw substantial increases in profitability, with operating income rising by 33% to $240.9 million and non-GAAP operating income expanding by 20% to $364.9 million.

Net income for the quarter was $236.2 million, marking a 27% increase from the prior year, while non-GAAP net income rose by 20% to $345.1 million. Earnings per share also reflected this growth, with fully diluted EPS climbing 24% to $1.40 and non-GAAP fully diluted EPS increasing by 16% to $2.04.

Looking ahead, Veeva provided guidance for the fourth quarter with expected total revenues between $807 million and $810 million, and a non-GAAP fully diluted net income per share of approximately $1.92. For the full fiscal year, the company anticipates revenues between $3,166 million and $3,169 million, with non-GAAP operating income around $1,417 million and non-GAAP EPS forecasted at $7.93. Veeva’s continued investment in AI and expansion of its customer base, including significant adoption of its Veeva Development Cloud, underscore its ongoing growth trajectory and commitment to innovation in the life sciences sector.

Earnings Trend Table

The analysis of the earnings per share (EPS) data over the observed quarters shows a consistent trend of surpassing estimated EPS figures. From December 2023 to November 2025, there is a clear upward trajectory in both estimated and reported EPS values. Initially, in December 2023, the estimated EPS was 1.30, with the reported EPS slightly higher at 1.34, representing a surprise percentage of 3.10%. This trend of outperforming estimates continues, with the surprise percentage generally increasing, reaching a peak of 13.30% in May 2025 when the reported EPS was 1.97 against an estimate of 1.74.

The incremental increases in both estimated and actual EPS suggest effective management forecasting and potentially conservative guidance, allowing the company to consistently exceed expectations. Between February 2024 and November 2025, the reported EPS increased from 1.38 to 2.04, showing robust growth. This consistent outperformance not only reflects positively on the company’s operational efficiency but also might influence investor confidence favorably, as the company demonstrates the ability to exceed financial projections steadily.

In the recent series of rating changes, there have been notable adjustments by various financial firms towards their stance on a specific stock.

1. BMO Capital Markets (Initiated on November 13, 2025): BMO Capital Markets initiated coverage on the stock with a “Market Perform” rating and set a target price of $300. This initiation suggests a neutral outlook, indicating that BMO expects the stock to perform in line with the broader market.

2. TD Cowen (Upgrade on October 7, 2025): TD Cowen upgraded their rating from “Hold” to “Buy,” and increased their target price to $380. This significant upgrade reflects a positive change in TD Cowen’s valuation assessment and outlook, suggesting stronger confidence in the stock’s future performance and potential market outperformance.

3. JP Morgan (Upgrade on September 8, 2025): JP Morgan upgraded their rating from “Neutral” to “Overweight” with a new target price of $330. This upgrade indicates a shift from a stance of neutrality to a more bullish perspective, implying that JP Morgan forecasts the stock to weigh more favorably against its peers.

4. Needham (Reiterated on May 29, 2025): Needham reiterated their “Buy” rating but adjusted the target price from $270 to $300. This reiteration and price adjustment suggest that Needham continues to view the stock favorably, while also accounting for new data or market conditions that justify a higher valuation.

These updates collectively reflect a generally positive shift in market sentiment regarding the stock, with multiple firms either upgrading their ratings or maintaining a positive outlook with adjusted target prices.

The current price of the stock is $246.72, which is notably lower than the average target price provided by various analysts. The recent ratings from BMO Capital Markets, TD Cowen, JP Morgan, and Needham suggest target prices ranging from $300 to $380, indicating a potential upside from the current market price.

TD Cowen presents the highest optimism with a target price of $380 following an upgrade from “Hold” to “Buy” as of October 2025. JP Morgan also shows a positive shift in their outlook, upgrading the stock from “Neutral” to “Overweight” and setting a target price at $330. Needham, maintaining a “Buy” rating, adjusted their target price from $270 to $300, reflecting continued confidence in the stock’s performance. BMO Capital Markets initiated coverage with a “Market Perform” rating and a target price of $300.

This consensus suggests a bullish sentiment among analysts, projecting growth potential for the stock based on their respective analyses.

Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.